jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Article

In Silico Antigenicity Screening of Moringa Coagulant

Namdeo Jadhav1★, Badrinath Bhawale1, Santosh Bhende1, Sushilkumar Patil2, Kailas Sonawane3★ Corresponding author

  1. 1Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur-416013, Maharashtra, India.
  2. 2Pharmacy Group, Birla Institute of Technology and Science, Pilani, Rajasthan.
  3. 3Department of Bioinformatics and Microbiology, Shivaji University, Kolhapur- 416013, Maharashtra, India.

CORRESPONDENCE

Namdeo Jadhav

Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur-416013, Maharashtra, India.

nrjadhav18@rediffmail.com

Received: 03-05-2012; Revised: 05-09-2012; Accepted: 29-11-2012.

Volume 47, Issue 2 · pp. 129–134 · PUBLISHED 2022 · DOI:

View on IJPER original site ↗

ABSTRACT

Moringa coagulant (MC) obtained from the seeds of plant moringa oleifera (family- Moringaceae) has been substantially investigated for water purification, but, scarcely pharmaceutical applications. Recent investigations state its utility in dissolution enhancement of poorly soluble drugs, amorphous state stabilization and extended drug release. To broaden the applications of MC as a pharmaceutical excipient, need has been felt to test its antigenicity owing to its proteinic nature. In silico antigenicity screening has been carried out to enable its use in formulation of both parenteral and oral dosage form. Virtual screening carried out using online servers (ProtScale Analysis, BcePred, ABCPred, HLA-DR4Pred) predicted the probable antigenic epitopes of MC using hydrophobicity, hydrophilicity, exposed surface, secondary structure, antigenic propensity scale etc. Using these servers, the most probable antigenic regions in MC were observed to be 2-10, 29-34 and 47-53. The studies demonstrate that, MC may not pose difficulty in formulation of nonparenteral dosage forms, but, if intended for parenteral delivery, its antigenic domain needs to be exhaustively investigated

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Jadhav, N., Bhawale, B., Bhende, S., Patil, S., & Sonawane, K. (2022). In Silico Antigenicity Screening of Moringa Coagulant. Indian Journal of Pharmaceutical Education and Research, 47(2), 129–134.